Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Internal Medicine | Critical Care | Emergency Medicine | Neurology | Psychiatry | Journal

Back to Journal Articles

Intervention Found to Improve Depression After Stroke

Last Updated: August 07, 2009.

 

Psychosocial-behavioral intervention plus antidepressant more effective than usual care

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
A brief psychosocial-behavioral intervention, when applied in addition to antidepressant treatment, can markedly reduce both short- and long-term depression following stroke, according to research published online Aug. 6 in Stroke.

FRIDAY, Aug. 7 (HealthDay News) -- A brief psychosocial-behavioral intervention, when applied in addition to antidepressant treatment, can markedly reduce both short- and long-term depression following stroke, according to research published online Aug. 6 in Stroke.

Pamela H. Mitchell, Ph.D., of the University of Washington in Seattle, and colleagues conducted a randomized study in 101 patients who were identified as clinically depressed after an ischemic stroke. Patients were divided into two groups and treated with either a brief psychosocial-behavioral intervention plus an antidepressant or usual care, including an antidepressant. Treatment was continued over eight weeks.

Compared with the usual-care group, the researchers found that patients in the intervention group had a significantly lower depression score both immediately after treatment and at 12 months. The mean percent decrease in depression score after 12 months was significantly greater in the intervention group compared with the usual-care group (47 versus 32 percent). Additionally, the authors note, significantly more of the patients in the intervention group were in remission both after treatment and at 12 months.

"A brief psychosocial-behavioral intervention adjunctive to antidepressant therapy is highly effective in reducing depression and achieving remission in the short term with the effect sustained for up to two years," the authors write. "Participants in the usual-care control group also reduced their depression over the first year, but more slowly and with a lesser degree of remission."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Infliximab Effective in Arthritis Resistant to Methotrexate Next: CDC Issues Guidance for Handling Influenza in Schools

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.